LIGAND PHARMACEUTICALS INCORPORATED Current Income Tax Expense (Benefit)
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Current Income Tax Expense (Benefit) of $12.62 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-27
- LIGAND PHARMACEUTICALS INCORPORATED current income tax expense (benefit) for fiscal 2025 was $12.62M, a 43.55% decline from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED current income tax expense (benefit) for fiscal 2024 was $22.35M.
- LIGAND PHARMACEUTICALS INCORPORATED current income tax expense (benefit) for fiscal 2023 was -$188.00K, a 101.75% decline from fiscal 2022.
- LIGAND PHARMACEUTICALS INCORPORATED current income tax expense (benefit) for fiscal 2022 was $10.74M, a 2352.51% increase from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 12 month | Current Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $12.62M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $22.35M 10-K · filed 2026-02-27 | |
| 2023-12-31 | -$188.00K 10-K · filed 2026-02-27 | |
| 2022-12-31 | $10.74M 10-K · filed 2025-02-28 | |
| 2021-12-31 | $438.00K 10-K · filed 2024-02-29 | -$1.22M 10-K · filed 2022-02-28 |
| 2020-12-31 | $11.38M 10-K · filed 2023-02-28 | $11.50M 10-K · filed 2021-02-24 |
| 2019-12-31 | $92.51M 10-K · filed 2022-02-28 | |
| 2018-12-31 | $266.00K 10-K · filed 2021-02-24 | |
| 2017-12-31 | $372.00K 10-K · filed 2020-02-27 | |
| 2016-12-31 | $33.00K 10-K · filed 2019-02-28 | |
| 2015-12-31 | $18.00K 10-K · filed 2018-03-01 | |
| 2014-12-31 | $34.00K 10-K · filed 2017-02-28 | $33.00K 10-K · filed 2014-12-01 |
| 2013-12-31 | $33.00K 10-K · filed 2016-11-14 | |
| 2012-12-31 | $19.00K 10-K · filed 2015-02-23 | |
| 2011-12-31 | $659.00K 10-K/A · filed 2014-12-12 | |
| 2010-12-31 | -$27.68M 10-K · filed 2013-03-14 |